Manco M, Castagneto-Gissey L, Arrighi E, et al. Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index[J]. PLoS One, 2014, 9 (4): e92995.
[2]
Sun J, Zhao J M, Ji R, et al. Effects of electroacupuncture of "Guanyuan" (CV 4)-"Zhongji" (CV 3) on ovarian P450 arom and P450c 17alpha expression and relevant sex hormone levels in rats with polycystic ovary syndrome[J]. Acupuncture Research, 2013, 38(6): 465-472.
[3]
Jones M R, Chazenbalk G, Xu N, et al. Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility[J]. The Journal of Clinical Endocrinology and Metabolism, 2012, 97(9): E1750- E1757.
[4]
Patel S S, Beshay V E, Escobar J C, et al. 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary[J]. Reproductive Sciences, 2010, 17(11): 978-986.
[5]
Ecklund L C, Usadi R S. Endocrine and reproductive effects of polycystic ovarian syndrome[J]. Obstetrics and Gynecology Clinics of North America, 2015, 42(1): 55-65.
[6]
Hofland J, Steenbergen J, Hofland L J, et al. Protein kinase C-induced activin A switches adrenocortical steroidogenesis to aldosterone by suppressing CYP17A1 expression[J]. American Journal of Physiology Endocrinology and Metabolism, 2013, 305(6): E736-E744.
[7]
Baptiste C G, Battista M C, Trottier A, et al. Insulin and hyperandrogenism in women with polycystic ovary syndrome[J]. The Journal of Steroid Biochemistry and Molecular Biology, 2010, 122(1-3): 42-52.
Abbott D H, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood[J]. Fertility and Sterility, 2013, 100(1): 2-11.
[10]
Hoang Y D, McTavish K J, Chang R J, et al. Paracrine regulation of theca androgen production by granulosa cells in the ovary[J]. Fertility and Sterility, 2013, 100(2): 561-567.
